LE Summit in Ohio in August
Comments
-
Rest up, all of you, but then we want all the details you can share with us. What struck you as important for the future of LE care? Were there any practical tips for our day-to-day struggles? Any real surprises?
Good choice on the chocolate! But I'll bet not one of those speakers mentioned how important chocolate is to LE management. Serious oversight!
Binney -
Okay Ohio attendees, isn't Jane Armer amazing?? Brilliant, one of us--got LE after bc--and never, ever complains, but does the work of several people.
First time I met her, she was giving a lecture at Stowe, at the Vodder recertification, and told the story of being told "not to worry about LE", and how within 6 months, she had it. I could hear a kindred spirit.
Her research is impeccable.
I got to spend a wonderful day with her at a LE meeting, in March, and I just adore her. Wish I had a fraction of her equanimity.
Special conference, with very special attendees.
-
Binney, to save myself some typing, I'll link to a post I just made in another thread, where I commented about the Summit after Becky made an interesting point about seeing lots of patients in compression wear. For those of you not following that thread, here's a link to the post:
http://community.breastcancer.org/forum/64/topic/787176?page=1#post_3162429
I'm going to be teaching a seminar tomorrow but hope to find time tomorrow night to reflect and report more on the summit.
Carol
-
Here's something else I thought of when posting on another thread: Jane Armer, at yesterday's LE summit, pointed out that the American LE Framework and (I think) NLN worked out an agreement that to become NAPBC-accredited (national accreditation program for breast centers), a breast center will have to include LE follow-up ( I think those were her words). Here's a link to the standards manual...do a ctrl+F search for 'lymphedema' and you'll find what's been inserted. I guess it's a start. http://napbc-breast.org/standards/2012standardsmanual.pdf
Carol
-
Hi Ladies,
It was great to finally "meet" you on Skype. I was in the dining room with my Mac and my husband heard me talk and laugh. In the morning, when I told him about Tina's vest and night sleeve, he thought it was a bit strange to talk about compression in the middle of the night! Carol, thank you for organizing this Skype meeting. What a wonderful group you are. With your knowledge, enthusiasm and support, we could move mountains here.
Becky, I can almost taste those chocolate bourbon truffles.
I wish I could have attended that conference with you all and listened to J. Armer, Dr. Paskett, Janice Cormier, etc. I am really looking forward to watching the recording of the conference next month.
Tina, this is a great picture. We would need a Bob Weiss here to help us fight with the local authorities that refuse to give referals for lymphedema therapy.
-
Jane Armer is amazing Kira!
I have to go to work today and tomorrow and will try to weigh in my comments on conference but may have to wait until weekend.
One leaves the conference on a high knowing there are people being proactive in the LE world.
-
Some of you asked those of us who attended the LE Summit to let you know what we learned. A lot! Here is my recap:
The first session was an overview of LE: What Causes It and Can It Be Prevented. It would be impossible to give all of the info we learned but three stood out to me. 1) Most survivors develop LE within 3 yrs of treatment while the remainder develop it at a rate of 1% a yr., 2) Current prevention knowledge is based more on clinical observation than research, 3) The negative effect of swelling on quality of life is well documented.
The second session was presented by a surgeon who does much surgery on melanoma--Janice Cormier. Her topic was LE Beyond Breast Cancer: Progress and Challenges. Since I had SNB with only two nodes taken out and was told my risk was only 1% I was interested in her chart that says LE studies following SNB ranged from 1-23% with an overall range of 6%. She also stated that a cancer survivor is not only the person who had cancer but family members, friends and caregivers who are also impacted by the survivorship experience, and are included in the definition of a cancer survivor.
The third session was presented by a Michael Bernas on LE Assessment, Genetics, and Imaging. He discussed different ways to measure which included water displacement, circumferential methods, and imaging. I was most interested in his discussion of lymphangioscintigraphy (can you pronounce it?). It is a minimally invasive procedure that depicts both the structure and functional status of the lymphatic system. I understood that it would determine if your swelling is indeed LE or due to other problems. It also depicts the path your individual lymphatic system is taking. Some studies are also underway on families that have LE.
The fourth session was by Jane Armer on the American Lymphedema Framework Project (ALFP) Update. The ALFP is a national collaborative initiative developed under the leadership of recognized clinical experts and investigators in the field of LE in the U.S. The ALFP will assess and promote appropriate health care services for patients with all forms of LE and advance the quality of care in the U.S. and worldwide. This encouraged me that we are not alone in our LE journey and efforts are being made to move forward in prevention, diagnosis, and treatment. More info can be seen at ALFP.org
The fifth session was by a Bob Stewart on Standardized Date Collection and Analysis to Assess the Magnitude of the LE Problem. This is Goal 2 under the ALFP. They are building a cyber framework for minimum data set deposit and analysis to share findings and knowledge between researchers and practitioner and to bring the latest findings to all levels of stakeholders.
The sixth session was by Jane Armer on Findings and Reflections from a Decade of Study in Breast Cancer Survivorship: Implications for Patients and Health Care Professionals. There was much information given on this. It is encouraging to know some data has been collected and will continue to be done. Some things from this presentation; 1) The variety of criteria used to identify LE, along with the lack of pretreatment measurements, are likely responsible for the wide range of LE occurrence rates reported in the literature; 2)Breast cancer survivors' perceived problem-solving was predictive of their perceived ability to cope with the LE symptoms as early as 12 months after breast cancer diagnosis; 3) She also discussed in detail the Limb Volume Change in women.
The seventh and last session was by Joseph Feldman on To Pump Or Not To Pump: a Systematic Review of Intermittent Compression Therapy. He discussed the history of pumps. Bottom line was 1) that before one uses a pump that they should have gone through a four week trial of conservative therapy that must include use of an appropriate compression bandage system or compression garment, exercise, and elevation of the limb, 2) the treating physician determines that there has been no significant improvement or if significant symptoms remain after the trial therpy, 3) the member has shown compliance in the previsous treatment options and is capable of following instructions that accompany the use of the LE pump. He also discussed the advantages and disadvantages of using the pump plus counterindications.
This may be more than all of you wanted to know. The others who attended may add more or correct me if I misunderstood any of the info. I wish all of you could have been there. It was totally worth it. It is so encouraging to know people are working tirelessly to try to gain more info on LE and a gold standard of treatment for all.
-
Thank you Becky!
-
Another thank you Becky.
-
Thanks, Becky!! Like you, I find it comforting to know that LE is getting more attention right now. I was reading an article posted somewhere here, that BC patients with lymph node procedures shouldn't raise their arms over their heads for a short time after (a week or two) to let the lymph system "reboot". The OT or whoever she was in the hospital gave me exercises that involved crawling my hands up the wall with the goal being over my head. Being a good patient, I did it with enthusiasm, and was excited how quickly I stretched that area back out and regained flexibility after my BMX. If only I had a time machine.... I learned about the lymph system at some point in science, but didn't really know how it functioned. Many of the people I describe my condition to don't know. That's not saying I wouldn't have developed LE anyway, they blasted the area with radiation because of a positive lymph node. But at the time, when they mentioned LE, it was a far away consequence and cancer was real & scary. Well, having dealt with LE for almost 3 years, it needs to be discussed more seriously before procedures/treatment, so patients are making an informed choice.
-
Becky,
Thank you very much for taking the time to write this report. Great job. Looking forward to watching the video of the conference.
Have a good week-end
-
Becky, I think your summary is spot-on, and I really have nothing to add! Gottalovened, your post-mx wall-walking experience happens all too often. The challenge is to get current LE standards of care into the hands of the MDs, surgeons, OTs, PTs...I recently looked at a current continuing education self-study for PTs, and even today, it instructs them to have post-breast surgery patients begin those exercises immediately.
Bahhhhh!!! It's incredibly frustrating to think that good information is out there for us, but only those in the LE community seem to have it. I was saved from that immediate exercise, not because anyone on my care team knew about its LE-risk consequences, but because I had microsurgical flap reconstruction, and the PS needed me to keep those arms down for two weeks, to protect the blood-vessel connections he had made. So saved for another reason...although I got LE anyway, although who knows, perhaps that's one reason my particular case of LE is very mild and easily controlled. The study you mention showed that the immediate exerciser group had 2.7 times the incidence of LE within the first year as the delayed exercisers, so of course, some of the delayed exercisers in the study did get LE. There are so many LE risks at play here!
Carol
-
Thanks, Becky!
-
Becky, thank you.
Excellent review, and so many different topics! Kinda makes your head swim. Being there to hear several people whose careers are all centered on lymphedema is such an encouragement. Sitting in our doctors' offices waiting to defend ourselves from blood pressure cuffs and stupid questions, we really have no sense of all the LE heroes who are working in so many ways to make our lives better.
All good!!
Binney -
Gottalovened: I was literally hanging from doorframes, because I thought I needed to maintain my shoulder motion after lumpectomy/SNB, and got a whooper seroma and a dozen cords, and LE three weeks out.
And, I sought the care of a PT trained in LE 2 weeks out, and she had me do MORE stretching and repetitive moves.....
I'll never know. Wish I didn't have to wonder.
-
Yep, I too thought I was being a 'good' girl with the exercises. I also got a seroma, cording and was told.........this is all normal. BLECH!!!
-
Thank you so much for going and the summary.
I am glad there were patients represented.
I wish there was a miracle in the pipeline, I must admit.
-
Cookie, a miracle cure will be a long time coming, but reading your wistful thought made me think of something else Jane Armer told us about. The ALFP is working with its European counterpart organization to develop diagnosis and treatment standards for LE, which today are all over the place--different diagnostic criteria, different measurement methods, different approaches to treatment--and all that variation means that it's difficult to know what to expect when we go for evaluation and treatment, and it also means there's not enough pooling of evidence about what's working and what's not. So wow to the ALFP and the European Framework for getting some standards in motion.
What's more, Jane also told us about ALFP and the European Framework project to systematically review all the major LE studies published (in the past ten years, I think). They are performing a quality assessment, which is needed because some studies have too few participants to be meaningful; some have such short follow-up that they're missing LE incidence after a year or less; and the studies, too, use different diagnostic criteria and different measurement methods. All of these problems mean that it's difficult to know if one study was well designed, and even if it was, it's difficult to compare to other study results, because the study designs could be quite different.
So...the ALFP is looking at the studies to tell us which ones are based on good science, and which ones are weak. And they are working on establishing diagnostic, measurement, and treatment standards, which I hope means that future studies will fall in line in those areas--making them more comparable, and helping to build a higher quality body of knowledge about LE.
None of this promises a miracle cure, but at least, it looks like the research and treatment communities are working toward some goals that will make research better, and treatments more consistent.
Jane also mentioned the movement to encourage the third party payers to recognize the value (financially and also in terms of our treatment outcomes) of 'prospective surveillance' --meaning all BC patients would be given pre-treatment baseline measures; we would be measured and our symptoms monitored very frequently from the beginning of BC treatment, and frequently afterward, to pick up LE at its earliest presentation. The idea is that the cost to screen all of us and then to treat the 33% or so who would be identified with early LE within a year, is less expensive AND more effective than not screening and measuring everyone, but instead just treating the few with LE that shows up in later stages, when it's harder and more expensive to treat. I asked her how likely it is today that our doctors, surgeons, etc. would pick up our LE based on minimal symptoms, because of course, they are not looking for it, and often they don't seem to want to hear about it from us. Jane's answer was that a national physical therapy organization has already scheduled a conference with payers, to present the prospective surveillance model, and it is hoped that the financial argument will win their cooperation. (That won't happen anytime soon, but it's a start to at least bring them together on it.)
Not one bit of this cures our LE today or this year, or maybe not this decade, but still, it's movement in the right direction.
And I learned something else encouraging recently, from a different resource--your very own Dr. Francis, who spoke by phone to a group of us who will participate in next month's NLN conference, in their advocacy program. Dr. Francis was reviewing and answering questions about the history of LE research, including some recent work. She pointed out that researchers have started to take interest in tissue changes that are common to both LE and obesity. The good news is that there are tons of dollars of money available for obesity research, and relatively little for LE-but that some common threads between LE and obesity mean that LE may piggyback on some kinds of research that would otherwise never be funded for us.
And one more thought: not only were patients represented at the LE Summit in Ohio; every single one of those amazing scientists spoke to us directly, with heartfelt interest in our well being, and they took great care to make their presentations quite understandable to those of us without all the degrees in science and in medicine. They were approachable, too--I introduced myself to Jane Armer and two others, and I asked questions that they gladly answered. In short: They care; they really do care, and it's much more than a job to them. (Of course, some--Jane Armer and Elektra Paskett--are in the sisterhood of swell...)
Carol
-
Becky and Carol, thanks for providing such an extensive summary of the presentations. So much information!
Carol, as someone who worked in a research library for several years, I will say the scope of that task is HUGE!! I was really impressed. And it's totally worth it to trace back to mine good data that meets the quality of work going forward. What a time consuming and painstaking job.
I thought Janice Cormier's straightforward comment as a surgeon, "I cause lymphedema; I don't treat it" was admirable. I know this wasn't the point of her presentation, but I didn't know a thing about skin cancer surgery. The complete removal of the axillary nodes for melanoma on the arm is standard. When you compare that to the possibility of SN or partial dissection for BC it seems extreme. Or, if the melanoma is located on the forearm, all of the nodes inside the elbow are removed as well. You would think the patients who have had skin cancer would really be stomping their feet about the best care for LE. At least Dr. Cormier talked about her patients going into surgery with their eyes wide open. I wish all surgeons who removed any nodes for whatever kind of surgery were required to inform their patients. She really should be commended on her willingness to address LE as a side effect to her work. I couldn't help but wonder if all skin cancer surgeons are as forthcoming.
I totally agree with you about the tone of the conference. I felt like we were one community with the same concerns and interest. I met more doctors in one day who were not afraid of LE patients than I have since my LE diagnosis three years ago! -
Well, I'm finally back on line after our whirlwind trip to Ohio & return to work.
Echoing agreement with everything discussed above and greatly appreciate Carol57's effort to get us together!
I thought the history of Jobst was interesting. In 1948, he noted that his swollen leg felt better when in waist deep lake water. I started doing a pool aerobics class once or twice a week earlier this year and think it has been therapeutic.
Another idea brought up, that I had not fully understood previously, was the concept of reflux - not only is normal lymphatic drainage blocked, but the fluid can actually "back up" into other tissues. More motivation to keep up with CDT and MLD.
Dr. Cormier was preaching to the choir so didn't really need to emphasize the phrase she uses in educational talks to other surgeons: If you don't ask, they (patients) won't tell, regarding LE symptoms. She knows many of her colleagues are in denial or not diagnosing promptly. Her clinic describes the perometer measure as the 6th vital sign, after temperature/pulse/blood pressure/respiratory rate, etc.
Dr. Feldman's background in establishing LANA and the credentialing process was impressive. Less than 15 years ago, no broadly accepted comprehensive certification standards were in place. They grew out of the NLN with grant money from the ACS.
Although I don't recall hearing them mentioned from the podium, there was literature in our packets describing the Treatment Act as well as LRF and their national registry program.
Sorry for all the acronyms used as shorthand. Anyone need a translation?
-
The new thread about NLN perceptions reminds me that a few weeks ago, I received an email from the folks at OSU announcing that the Summit presentation recordings are now available for viewing on an OSU website: Lymphedema Summit Presentations
I have not used the link to take a peek, but if anyone finds it does not work, post here and I'll follow up with the Summit presenters.
-
Hi Carol,
Thanks for the link. I checked it and I found out the following:
- This link takes you to a page with a list of the presentations, each of them has two sub-links - one for a PPT presentation and one for a video.
- All the PPT links are working fine.
- As far as the videos are concerned, some are not working well.
- Links for videos 1, 4 and 5 are alright (YouTube videos)
- Links for videos 2, 3 and 6 (OSU own network??) are inaudible
- Link for video 7 is not working at all. (Takes me to Google page asking me to create a YouTube account...)
Anybody else has the same problem with the OSU videos?
-
I still haven't had time to check, but I will send your comments to the person who sent me the page link. Thanks, Nitocris, for trying the link out!
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team